ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
FDA halts Bellicum trial over brain disease in participants, shares crash 48%
pharmafile
February 02, 2018Texas-based clinical-stage company Bellicum Pharmaceuticals has taken a massive stock hit after the FDA put a hold on its trials of its T-cell therapy BPX-501 due to three cases of encephalopathy in participants that are thought to be treatment-related. -
NHL Veterans Pledge Their Brains to Research
drugs.com
February 24, 2017Several former National Hockey League players have joined the growing number of pro athletes who have pledged their brains to research on chronic traumatic encephalopathy (CTE) -- a devastating brain disease that has been linked to repetitive head trauma.
Pharma Sources Insight January 2025
